Literature DB >> 15922485

Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury.

Chen-Guang Yu1, Robert P Yezierski.   

Abstract

The role of the ERK1/2 signal transduction pathway and related transcription factors in the regulation of gene expression and pain behavior following excitotoxic spinal cord injury (SCI) was examined. Specifically, phosphorylation of ERK1/2, activation of transcription factors NF-kB, ELK-1, and CREB, and gene expression of the neurokinin-1 receptor and NMDA receptor subunits NR1 and NR-2A were investigated. Excitotoxic injury was produced by intraspinal injection of quisqualic acid (QUIS) in male Sprague-Dawley rats. Western blots were used to evaluate phosphorylation and activation of ERK1/2 and transcription factors using phospho-specific or total antibodies. Real-time PCR was used to evaluate gene expression of NK-1R, NR-1, and NR-2A. Assessment of excessive grooming behavior was used to evaluate the presence of spontaneous pain behavior. Excitotoxic spinal injury resulted in: (1) increased phosphorylation of ERK1/2; (2) increased activation of NF-kB and phosphorylation of ELK-1; and (3) increased gene expression for the NK-1 receptor and NR1 and NR-2A subunits of the NMDA receptor. Blockade of the ERK cascade with the MEK inhibitor PD98059 inhibited phosphorylation of ELK-1, activation of NF-kB and gene expression of NR1, NR-2A and NK-1R, and prevented the development of excessive grooming behavior. The results have shown that excitotoxic spinal injury leads to the injury-induced activation of the ERK-->ELK-1 and NF-kB signaling cascades and transcriptional regulation of receptors important in the development of chronic pain. Blockade of this intracellular kinase cascade prevented the onset of injury-induced pain behavior.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922485     DOI: 10.1016/j.molbrainres.2005.04.013

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  26 in total

1.  Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury.

Authors:  Darryl Lau; Steven E Harte; Thomas J Morrow; Shiyong Wang; Marina Mata; David J Fink
Journal:  Neurorehabil Neural Repair       Date:  2012-05-15       Impact factor: 3.919

2.  Spinal cord injuries containing asymmetrical damage in the ventrolateral funiculus is associated with a higher incidence of at-level allodynia.

Authors:  Bradley J Hall; Jason E Lally; Eric V Vukmanic; James E Armstrong; Jason D Fell; Daya S Gupta; Charles H Hubscher
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

Review 3.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

Review 4.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

Review 5.  Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms.

Authors:  Andrea Truini; Luis Garcia-Larrea; Giorgio Cruccu
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937

6.  Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism.

Authors:  Ronald R Seese; Anna R Maske; Gary Lynch; Christine M Gall
Journal:  Neuropsychopharmacology       Date:  2014-01-22       Impact factor: 7.853

7.  Temporospatial expression of fibulin-1 after acute spinal cord injury in rats.

Authors:  Guanhua Xu; Ying Cui; Lingling Wang; Jinlong Zhang; Aiguo Shen; Weidong Li; Guofeng Bao; Yuyu Sun; Zhiming Cui
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

8.  Protective effects of hyperbaric oxygen treatment against spinal cord injury in rats via toll-like receptor 2/nuclear factor-κB signaling.

Authors:  Jiewen Tan; Fang Zhang; Fang Liang; Yong Wang; Zhuo Li; Jing Yang; Xuehua Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Activation of p-38alpha MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury.

Authors:  Young S Gwak; Geda C Unabia; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2009-08-20       Impact factor: 5.330

10.  Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury.

Authors:  Eric D Crown; Young Seob Gwak; Zaiming Ye; Kathia M Johnson; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2008-06-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.